Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Raised to $89 at Truist Securities

August 5, 2021 6:29 AM
Truist Securities analyst Samuel Brodovsky raised the price target on Globus Medical (NYSE: GMED) to $89.00 (from $82.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles